A previous version of this wire story misstated that DiPascali was released.

A previous version of this story misstated Johnson & Johnson's patent issues. Remicade's patent lasts until 2018, and Velcade's patent lasts until 2015. Floxin has already lost patent protection.

A previous version of this story misstated Public Spaces, rather than Free People, as an Urban Outfitters store.

An earlier version of this story misstated McAfee's earnings-per-share in the year-ago period as 63 cents a share.

A previous version of this story incorrectly stated the revised GDP forecast. Goldman Sachs cut the forecast to 2.7 percent from 3.0 percent.

The CNBC European Business Leaders Awards, created to identify and honor CEOs who are making a difference through leadership and innovation, enters its seventh year in 2010.

A previous version of this story inadverdently listed Cramer's charitable trust as owning Caterpillar.

A video from Oct. 20, 2009, "Steve Case on the Economy, Tech & More," had an incorrect television caption regarding WebMD. WebMD is a publicly traded company, WebMD Health Corp. (Ticker: WBMD), and is not owned by Waterfront Media.

A previous version of this story inadverdently listed Cramer's charitable trust as owning Caterpillar.

A story from Sept. 20, 2008, "Morgan Stanley: US Plan a Game Changer," was mistakenly republished and distributed through automatic feeds.

An earlier version of this story reported that some patients had experienced "higher" triglycerides. Actually the patients reportedly experienced "lower" triglycerides.

An earlier version of the story misidentified AutoNation CEO Mike Jackson's company as AutoZone.

An earlier version of this story incorrectly identified eSwarm as a group buying Web site. The company operates a social networking service.

An earlier version of this story misstated the amount of Goldman Sachs earnings, listing them as $344 billion when it should have read $3.44 billion.

An earlier version of this story provided an adjusted earnings per share figure instead of a net income earnings per share figure for the year-ago period.

An earlier posting stated that Michael Jackson's 50 percent stake of the Sony/ATV Music Publishing holdings could be worth as much a $500 million.

An earlier posting misstated a figure in these results. The correction has been made.

GM CFO Ray Young said that the new GM would not see a positive cash flow until 2010. An earlier version of the story inadvertently listed the year as 2009. 

Hertz Global expects its second quarter revenue to be between $1.7 billion and $1.75 billion. An earlier version of this story incorrectly stated the value to be $1.7 million to $1.75 million.

S&P cut its outlook but left the rating intact for PNC Financial Services, First National Bank of Omaha, M&T Bank and Valley National Bancorp. An earlier report inaccurately indicated that the ratings were cut for those institutions.

A previous version of this story indicated that the existing UAL Corp. has traded since February. It has been trading since February 2, 2006.

After the original post was published, Kitano hotel clarified that its $8 special on beer, wine and appetizers ended last week.

In the original post, the story's headline incorrectly suggested that Zell had left the Tribune Company

This story listed United Technologies' George David as the company's CEO. He is the former CEO, and is now serving as chairman.

A previous version of this story incorrectly stated that Health Care REIT's CEO, George L. Chapman, had recently resigned. It was former President Raymond W. Braun who resigned, in January 2009.

Correction: The original story mis-stated the reason why Apple founder Steve Jobs took a leave of absence in January. He left for undisclosed health reasons.

The original story stated that SLM Corp. fell $54 on news that President Obama planned to overhaul the student-loan business. In fact, at publish time the stock was down $54 from where it received a takeover bid in April 2007.

Originally listed as an industry laggard was Life Techonolgies (LIFE), but it was brought to the attention of CNBC that due to a recent merger of companies, ThomsonReuters data did not reflect the combined revenues for Life Technologies over the past 12 months. This ranking has been changed to reflect this correction.

This blog post originally mis-characterized the nature of a Web site.

A previous version of this story listed Rio Tinto as a Brazilian company. The correct firm was Companhia Vale do Rio Doce.

This story was corrected to show Bob Diamond said Barclays will not need to raise new capital. It originally reported Diamond as saying the bank would not need to raise new capital in the next six months.

The slide concerning Lear Corp. had an incorrect image.

Correction: A statement made by Luxury Mortgage Corp. indicated that borrowers needed to be delinquent in order to qualify for the FNMA program known as Hope Now Streamlined Mortgage Modification Plan. However, the subject matter of the article that the quote was used in was meant to address the new and recently released FNMA program known as the Homeowner Affordability and Stability Plan. Luxury Mortgage Corp. would like to clarify that borrowers do not have to be delinquent on their mortgage in order to qualify for this new modification plan. Therefore, borrowers that are current on their mortgage may qualify for the Homeowner Affordability and Stability Plan.

Correction: A video clip, "Director Luc Besson on the Film Industry's Outlook," was incorrectly edited to make it appear as though Mr. Besson was interested in making acquisitions. In fact, Mr. Besson is NOT interested in making any acquisitions. CNBC regrets any confusion this error may have caused.

Correction: A story that appeared on Feb 27th said that a quarter of Schwab investors use ETFs as their primary way to trade when it should have said a quarter of active investors surveyed by Charles Schwab use ETFs as their primary way to trade.

Correction: A story that appeared on Feb. 13 erroneously stated that CV Therapeutics agreed to a $1 billion takeover bid by pharmaceutical firm Astellas Pharma. There has been no agreement.

It is CNBC.com's policy to correct factual errors and clarify confusing statements. Significant errors of fact and substance are noted on this page as well as on the page originally containing the error. Minor errors of spelling, punctuation and grammar will be corrected on our Web site without notice. If you think CNBC.com has published something in error, please email us at youropinion@cnbc.com.